CareRx Corporation

Toronto Stock Exchange CRRX.TO

CareRx Corporation Total Non-Current Liabilities for the year ending December 31, 2023: USD 66.33 M

CareRx Corporation Total Non-Current Liabilities is USD 66.33 M for the year ending December 31, 2023, a -33.97% change year over year. Total non-current liabilities are the sum of long-term debt and other non-current liabilities.
  • CareRx Corporation Total Non-Current Liabilities for the year ending December 31, 2022 was USD 100.47 M, a -13.88% change year over year.
  • CareRx Corporation Total Non-Current Liabilities for the year ending December 31, 2021 was USD 116.66 M, a 46.51% change year over year.
  • CareRx Corporation Total Non-Current Liabilities for the year ending December 31, 2020 was USD 79.62 M, a 165.20% change year over year.
  • CareRx Corporation Total Non-Current Liabilities for the year ending December 31, 2019 was USD 30.02 M, a 93.12% change year over year.
Key data
Date Total Non-Current Liabilities Shareholders' Equity Other Liabilities Total Liabilities
Market news
Loading...
Toronto Stock Exchange: CRRX.TO

CareRx Corporation

CEO Mr. Puneet Khanna
IPO Date Feb. 13, 2008
Location Canada
Headquarters 20 Eglinton Avenue West
Employees 1,432
Sector Health Care
Industries
Description

CareRx Corporation, together with its subsidiaries, provides specialty pharmacy services to seniors in Canada. The company operates a network of pharmacy fulfilment centers that provide chronic medication and other specialty clinical pharmacy services. It serves approximately 50,000 residents in approximately 900 seniors and other communities, including long-term care homes, retirement homes, assisted living facilities, and group homes. The company was formerly known as Centric Health Corporation and changed its name to CareRx Corporation in June 2020. CareRx Corporation was incorporated in 2001 and is headquartered in Toronto, Canada.

Similar companies

VLN.TO

Velan Inc.

USD 8.19

-0.12%

DTOL.TO

D2L Inc.

USD 12.29

1.02%

StockViz Staff

January 16, 2025

Any question? Send us an email